Solasto Corp
TSE:6197

Watchlist Manager
Solasto Corp Logo
Solasto Corp
TSE:6197
Watchlist
Price: 1 117 JPY Market Closed
Market Cap: ¥105.8B

EV/EBIT

15.2
Current
32%
More Expensive
vs 3-y average of 11.6

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
15.2
=
Enterprise Value
¥84.6B
/
EBIT
¥6.6B

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
15.2
=
Enterprise Value
¥84.6B
/
EBIT
¥6.6B

Valuation Scenarios

Solasto Corp is trading above its 3-year average

If EV/EBIT returns to its 3-Year Average (11.6), the stock would be worth ¥846.83 (24% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-24%
Maximum Upside
No Upside Scenarios
Average Downside
17%
Scenario EV/EBIT Value Implied Price Upside/Downside
Current Multiple 15.2 ¥1 117
0%
3-Year Average 11.6 ¥846.83
-24%
5-Year Average 12.9 ¥941.69
-16%
Industry Average 12.7 ¥931.23
-17%
Country Average 13.6 ¥998.62
-11%

Forward EV/EBIT
Today’s price vs future ebit

Not enough data available to calculate forward EV/EBIT

Peer Comparison

All Multiples
EV/EBIT
P/E
All Countries
Close
Market Cap EV/EBIT P/E
JP
Solasto Corp
TSE:6197
101.6B JPY 15.2 24
US
CVS Health Corp
NYSE:CVS
99.1B USD 14.2 56
US
Cigna Group
XMUN:CGN
69.7B EUR 10 13.5
US
Cigna Corp
NYSE:CI
72.6B USD 0 12.2
DE
Fresenius Medical Care AG
XMUN:FME
23.1B EUR 16.8 23.6
DE
Fresenius SE & Co KGaA
XETRA:FRE
22.7B EUR 13.7 17.9
US
Quest Diagnostics Inc
NYSE:DGX
21.8B USD 15.8 21.4
US
Laboratory Corporation of America Holdings
NYSE:LH
21.7B USD 17.2 24.7
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.8B EUR 9.9 11.1
US
Guardant Health Inc
NASDAQ:GH
11.6B USD -27.7 -27.9
US
DaVita Inc
NYSE:DVA
10.4B USD 9.8 13.9
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
JP
Solasto Corp
TSE:6197
Average EV/EBIT: 13.6
15.2
N/A N/A
US
CVS Health Corp
NYSE:CVS
14.2
22%
0.6
US
C
Cigna Group
XMUN:CGN
10
5%
2
US
Cigna Corp
NYSE:CI
Not Available N/A N/A
DE
Fresenius Medical Care AG
XMUN:FME
16.8
11%
1.5
DE
Fresenius SE & Co KGaA
XETRA:FRE
13.7
12%
1.1
US
Quest Diagnostics Inc
NYSE:DGX
15.8
9%
1.8
US
Laboratory Corporation of America Holdings
NYSE:LH
17.2
18%
1
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
9.9
11%
0.9
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -27.7 N/A N/A
US
DaVita Inc
NYSE:DVA
9.8
5%
2

Market Distribution

In line with most companies in Japan
Percentile
59th
Based on 4 801 companies
59th percentile
15.2
Low
0.1 — 9.8
Typical Range
9.8 — 18.1
High
18.1 —
Distribution Statistics
Japan
Min 0.1
30th Percentile 9.8
Median 13.6
70th Percentile 18.1
Max 414 821 439

Solasto Corp
Glance View

Market Cap
105.8B JPY
Industry
Health Care

Solasto Corp. engages in the provision of medical and welfare-related services. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 29,838 full-time employees. The company went IPO on 2016-06-29. The firm has two business segments. The Medical Related Contract segment is engaged in the provision of contract and staffing services such as reception, accounting, medical fee billing, hospital management support and other medical office related services. The Nursing Care And Childcare segment is engaged in the provision of home help services, day services, paid nursing homes with long-term care services, care houses, residential-type paid elderly homes, home care support services, group homes, home-visit nursing care services, childcare services, as well as the rental and sale of welfare equipment. The firm is also engaged in the provision of education and training services such as medical and nursing care related courses, the skill certification test business, the real estate leasing business, and the insurance agency business.

Intrinsic Value
909.39 JPY
Overvaluation 19%
Intrinsic Value
Price ¥1 117
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett